Kudoh S - Search Results

1

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.

Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC. Seike M, et al. Among authors: kudoh s. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12085-90. doi: 10.1073/pnas.0905234106. Epub 2009 Jul 13. Proc Natl Acad Sci U S A. 2009. PMID: 19597153 Free PMC article.

2

Proteomic signatures for histological types of lung cancer.

Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S. Seike M, et al. Among authors: kudoh s. Proteomics. 2005 Jul;5(11):2939-48. doi: 10.1002/pmic.200401166. Proteomics. 2005. PMID: 15996008

3

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

Seike M, Yanaihara N, Bowman ED, Zanetti KA, Budhu A, Kumamoto K, Mechanic LE, Matsumoto S, Yokota J, Shibata T, Sugimura H, Gemma A, Kudoh S, Wang XW, Harris CC. Seike M, et al. Among authors: kudoh s. J Natl Cancer Inst. 2007 Aug 15;99(16):1257-69. doi: 10.1093/jnci/djm083. Epub 2007 Aug 8. J Natl Cancer Inst. 2007. PMID: 17686824

4

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.

Noro R, Gemma A, Kosaihira S, Kokubo Y, Chen M, Seike M, Kataoka K, Matsuda K, Okano T, Minegishi Y, Yoshimura A, Kudoh S. Noro R, et al. Among authors: kudoh s. BMC Cancer. 2006 Dec 6;6:277. doi: 10.1186/1471-2407-6-277. BMC Cancer. 2006. PMID: 17150102 Free PMC article.

5

PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

Noro R, Gemma A, Miyanaga A, Kosaihira S, Minegishi Y, Nara M, Kokubo Y, Seike M, Kataoka K, Matsuda K, Okano T, Yoshimura A, Kudoh S. Noro R, et al. Among authors: kudoh s. Int J Oncol. 2007 Nov;31(5):1157-63. Int J Oncol. 2007. PMID: 17912443

6

Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S. Okano T, et al. Among authors: kudoh s. Oncol Rep. 2006 Mar;15(3):545-9. Oncol Rep. 2006. PMID: 16465410

7

Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.

Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S. Yoshimura A, et al. Among authors: kudoh s. Genes Chromosomes Cancer. 2003 Jun;37(2):159-64. doi: 10.1002/gcc.10205. Genes Chromosomes Cancer. 2003. PMID: 12696064

8

[Iressa (gefitinib)].

Kudoh S, Yoshimura A, Gemma A. Kudoh S, et al. Gan To Kagaku Ryoho. 2003 Aug;30(8):1079-84. Gan To Kagaku Ryoho. 2003. PMID: 12938261 Review. Japanese.

9

Proteomic signature of human cancer cells.

Seike M, Kondo T, Fujii K, Yamada T, Gemma A, Kudoh S, Hirohashi S. Seike M, et al. Among authors: kudoh s. Proteomics. 2004 Sep;4(9):2776-88. doi: 10.1002/pmic.200300795. Proteomics. 2004. PMID: 15352251

10

Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.

Okano T, Kondo T, Fujii K, Nishimura T, Takano T, Ohe Y, Tsuta K, Matsuno Y, Gemma A, Kato H, Kudoh S, Hirohashi S. Okano T, et al. Among authors: kudoh s. Clin Cancer Res. 2007 Feb 1;13(3):799-805. doi: 10.1158/1078-0432.CCR-06-1654. Clin Cancer Res. 2007. PMID: 17289870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters